KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis

J Immunol. 2013 Apr 1;190(7):3216-24. doi: 10.4049/jimmunol.1202926. Epub 2013 Feb 25.

Abstract

The human leukocyte Ag HLA-B27 (B27) is strongly associated with the spondyloarthritides. B27 can be expressed at the cell surface of APC as both classical β2-microglobulin-associated B27 and B27 free H chain forms (FHC), including disulfide-bonded H chain homodimers (termed B27(2)). B27 FHC forms, but not classical B27, bind to KIR3DL2. HLA-A3, which is not associated with spondyloarthritis (SpA), is also a ligand for KIR3DL2. In this study, we show that B27(2) and B27 FHC bind more strongly to KIR3DL2 than other HLA-class I, including HLA-A3. B27(2) tetramers bound KIR3DL2-transfected cells more strongly than HLA-A3. KIR3DL2Fc bound to HLA-B27-transfected cells more strongly than to cells transfected with other HLA-class I. KIR3DL2Fc pulled down multimeric, dimeric, and monomeric FHC from HLA-B27-expressing cell lines. Binding to B27(2) and B27 FHC stimulated greater KIR3DL2 phosphorylation than HLA-A3. B27(2) and B27 FHC stimulated KIR3DL2CD3ε-transduced T cell IL-2 production to a greater extent than control HLA-class I. KIR3DL2 binding to B27 inhibited NK IFN-γ secretion and promoted greater survival of KIR3DL2(+) CD4 T and NK cells than binding to other HLA-class I. KIR3DL2(+) T cells from B27(+) SpA patients proliferated more in response to Ag presented by syngeneic APC than the same T cell subset from healthy and disease controls. Our results suggest that expansion of KIR3DL2-expressing leukocytes observed in B27(+) SpA may be explained by the stronger interaction of KIR3DL2 with B27 FHC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens / immunology
  • Cell Line
  • Cell Survival / immunology
  • Cells, Cultured
  • HLA-A3 Antigen / immunology
  • HLA-A3 Antigen / metabolism
  • HLA-B27 Antigen / chemistry
  • HLA-B27 Antigen / immunology
  • HLA-B27 Antigen / metabolism*
  • HLA-B35 Antigen / immunology
  • HLA-B35 Antigen / metabolism
  • HLA-B7 Antigen / immunology
  • HLA-B7 Antigen / metabolism
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Interferon-gamma / biosynthesis
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Protein Binding
  • Protein Multimerization
  • Receptors, KIR3DL2 / genetics
  • Receptors, KIR3DL2 / immunology
  • Receptors, KIR3DL2 / metabolism*
  • Spondylitis, Ankylosing / genetics
  • Spondylitis, Ankylosing / immunology*
  • Spondylitis, Ankylosing / metabolism*
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism

Substances

  • Antigens
  • HLA-A3 Antigen
  • HLA-B27 Antigen
  • HLA-B35 Antigen
  • HLA-B7 Antigen
  • Histocompatibility Antigens Class I
  • KIR3DL2 protein, human
  • Receptors, KIR3DL2
  • Interferon-gamma